Editorial: Should we treat aging as a disease? Academic, pharmaceutical, healthcare policy, and pension fund perspectives

Frontiers in Genetics

Volumn 7, Issue FEB, 2016, Pages

  Zhavoronkov, Alex ^a,b,c   Moskalev, Alexey ^b,d,e  

^a The Biogerontology Research Foundation   (United Kingdom)

^b Insilico Medicine Inc   (United States)

^c Federal Research and Clinical Center of Pediatric Hematology   (Russian Federation)

^d INSTITUTE OF BIOLOGY   (Russian Federation)

^e MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

Author keywords

Aging disease; Biogerontology; Geroprotectors; ICD 11; Longevity risk; WHO

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGING; DISEASES; ECONOMIC ASPECT; EDITORIAL; HEALTH CARE POLICY; HUMAN; PENSION; PHARMACEUTICAL CARE; WORLD HEALTH ORGANIZATION;

EID: 84962548621     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2016.00017     Document Type: Editorial

References (15)

1. Aliper, A. M., Csoka, A. B., Buzdin, A. Jetka, T., Roumiantsev, S., Moskalev, A., et al. (2015). Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging 7, 26-37.
2. Duncan, D. E. (2012). How Long Do You Want To Live? New York, NY: N. Y. Times.
3. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2013). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128. doi: 10.1016/S0140-6736(12)61728-0)
4. Makarev, E., Cantor, C., Zhavoronkov, A., Buzdin, A., Aliper, A., and Csoka, A. B. (2014). Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions. Aging (Albany. NY). 6, 1064-1075.
5. Moskalev, A. A., Aliper, A. M., Smit-McBride, Z., Buzdin, A., and Zhavoronkov, A. (2014). Genetics and epigenetics of aging and longevity. Cell Cycle 13, 1063-1077. doi: 10.4161/cc.28433
6. Moskalev, A., Chernyagina, E., de Magalhães, J. P., Barardo, D., Thoppil, H., Shaposhnikov, M., et al. (2015). Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease. Aging (Albany. NY). 7, 616-628.
7. Murray, C. J. L., and Lopez, A. D. (1996). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, MA: Harvard School of Public Health on behalf of the World Health Organization and the World Bank.
8. Pew Research Center (2013). Living to 120 and Beyond: Americans' Views on Aging, Medical Advances and Radical Life Extension. Washington, DC: Pew Research Center Religion and Public Life Project.
9. Tacutu, R., Budovsky, A., Yanai, H., and Fraifeld, V. E. (2011). Molecular links between cellular senescence, longevity and age-related diseases-a systems biology perspective. Aging (Albany. NY) 3, 1178-1191.
10. World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
11. Zhavoronkov, A. (2013). The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy. New York, NY: Palgrave Macmillan.
12. Zhavoronkov, A. (2015). Longevity expectations in the pension fund, insurance, and employee benefits industries. Psychol. Res. Behav. Manag. 8, 27-39. doi: 10.2147/PRBM.S75440)
13. Zhavoronkov, A., and Cantor, C. R. (2011). Methods for structuring scientific knowledge from many areas related to aging research. PLoS ONE 6:e22597. doi: 10.1371/journal.pone.0022597
14. Zhavoronkov, A., Debonneuil, E., Mirza, N., and Artyuhov, I. (2012). Evaluating the impact of recent advances in biomedical sciences and the possible mortality decreases on the future of healthcare and Social Security in the United States. Pensions Int. J. 17, 241-251. doi: 10.1057/pm.2012.28
15. Zhavoronkov, A., and Litovchenko, M. (2013). Biomedical progress rates as new parameters for models of economic growth in developed countries. Int. J. Environ. Res. Public Health 10, 5936-5952. doi: 10.3390/ijerph10115936